Dr Kenneth Sooi is an Associate Consultant with the National University Cancer Institute Singapore. He completed his undergraduate medical training at the Yong Loo Lin School of Medicine and post-graduate training in internal medicine and medical oncology at the National University Health System, Singapore. He served as the chief senior resident of the medical oncology programme from 2022-2023. His areas of clinical and research interest include lung and thoracic cancers.
Dr Sooi is dedicated to medical education and is actively involved in teaching the younger generation. He has received education recognition awards in 2022 and currently serves as a core faculty member of the medical oncology senior residency program.
2022 - Faculty Recognition Award (Department of Medicine)
1. Sooi K, Walsh R, Kumarakulasinghe N, Wong A, Ngoi N. A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer. Cancer Drug Resistance 2023. 6(3):656-73. doi:10.20517/cdr.2023.48
2. Sooi K, JL Low, Q Miow, Kumarakulasinghe N, Sundar R, Y Huang. Pan-immune-inflammation value as a predictive biomarker for survival in advanced non-small cell lung cancer patients treated with immunotherapy. Journal of Clinical Oncology 2022. 40(16_suppl):e21095-e21095.
doi:10.1200/JCO.2022.40.16_suppl.e21095
3. JL Low, Huang Y, Sooi K et al. Low dose pembrolizumab in the treatment of advanced non-small cell lung cancer. International Journal of Cancer. 2021; 149(1):169-176. doi: 10.1002/ijc.33534.
Member, American Society of Clinical Oncology
Member, European Society of Medical Oncology
